This could have been prevented. More than a decade ago, David Kessler, former FDA commissioner, issued a warning about
the future of compounded drugs at a Congressional hearing prior to
passage of the Food and Drug Administration Modernization Act of 1997.
He said that ambiguity in the law could allow for “large scale
manufacturing under the guise of pharmacy compounding,” leading to a
“shadow industry” of unapproved generic drugs.
An Iv-B and Oy-R business caused by weak I-O regulation, it is like the shadow banking industry that led to the GFC. The FDC was not permitted to police it which is like Clinton and later Greenspan preventing regulation of derivatives.
An Iv-B and Oy-R business caused by weak I-O regulation, it is like the shadow banking industry that led to the GFC. The FDC was not permitted to police it which is like Clinton and later Greenspan preventing regulation of derivatives.
Provisions
in the act designed to clarify FDA oversight of compounding pharmacies —
including restrictions on their ability to advertise drugs — were later
struck down by courts. Still, the FDA says it can act in some
circumstances, such as when a drug is contaminated or mislabeled.
Miller
said he believes only a few rogue compounding pharmacies are operating
outside traditional boundaries. The New England Compounding Center
“appears to have been acting as a manufacturer without being registered
as a manufacturer with the (Food and Drug Administration), or
registering with the Massachusetts Board of Pharmacy as a manufacturer,”
he said.
“Something
does need to change. That’s something our association is grappling with
right now,” he said. In the wake of the outbreak, officials from the
academy are in contact with congressional staffers to discuss how to
increase oversight without stifling traditional pharmacy practices,
Miller added.
Other cases have raised alarms. In 2007, a Portland Tribune investigation revealed patient deaths that
were linked to a bad batch of drugs, used to treat back pain, from a
Texas compounding pharmacy. A pharmacist who consults with the advocacy
group Public Citizen called the compounding pharmacy industry a “shadow
drug industry,” in an interview with the newspaper.The Iv pharmacies and B patients create chaos between them, they interact with each other having no police or public Bi discussion to moderate their behavior so it grows to a ceiling and then crashes to a floor.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.